JLK,Inc. Stock

Equities

A322510

KR7322510009

Software

End-of-day quote Korea S.E. 06:00:00 2024-05-27 pm EDT 5-day change 1st Jan Change
14,410 KRW +6.98% Intraday chart for JLK,Inc. -3.03% -34.35%
Sales 2022 3.42B 2.5M Sales 2023 2.49B 1.82M Capitalization 348B 254M
Net income 2022 -9.01B -6.6M Net income 2023 -7.32B -5.36M EV / Sales 2022 16.3 x
Net Debt 2022 8.31B 6.08M Net Debt 2023 11.95B 8.75M EV / Sales 2023 144 x
P/E ratio 2022
-5.21 x
P/E ratio 2023
-46.8 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 74.21%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.98%
1 week-3.03%
Current month+20.18%
1 month+37.37%
3 months+6.03%
6 months-31.71%
Current year-34.35%
More quotes
1 week
12 600.00
Extreme 12600
14 800.00
1 month
10 330.00
Extreme 10330
15 880.00
Current year
8 990.00
Extreme 8990
24 900.00
1 year
8 990.00
Extreme 8990
39 050.00
3 years
3 100.00
Extreme 3100
39 050.00
5 years
3 100.00
Extreme 3100
39 050.00
10 years
3 100.00
Extreme 3100
39 050.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 -
Founder 59 14-02-17
Members of the board TitleAgeSince
Founder 59 14-02-17
Chief Executive Officer 47 -
More insiders
Date Price Change Volume
24-05-28 14,410 +6.98% 989,091
24-05-27 13,470 +5.73% 639,280
24-05-24 12,740 -6.94% 439,981
24-05-23 13,690 -4.47% 558,557
24-05-22 14,330 -3.57% 404,738

End-of-day quote Korea S.E., May 27, 2024

More quotes
JLK Inc, formerly JLK Inspection Inc, is a Korea-based company principally engaged in the development of artificial intelligence (AI) software. The Company develops software including AI medical analysis solutions, AI industry and security analysis solutions and others. Medical diagnostic platforms consist of AI medical systems, AI quantitative analysis platforms, AI remote platforms, AI medical diagnostic platforms, among others.
More about the company
  1. Stock Market
  2. Equities
  3. A322510 Stock